Health Affairs

Health Affairs, 25, no. 5 (2006): 1205-1217 doi: 10.1377/hlthaff.25.5.1205 © 2006 by Project HOPE	New Online   Getting Health Reform Done   After the State of the Union   Incremental Reform   E-Health in Developing World   Most-Read Articles in 2009

This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Robinson, J. C. Search for Related Content PubMed PubMed Citation Articles by Robinson, J. C. Related Collections Access To Care Insurance Coverage Business Of Health Pharmaceuticals Research And Technology Health Spending Consumer Issues

Coverage

Insurers’ Strategies For Managing The Use And Cost Of Biopharmaceuticals

James C. Robinson

This paper examines strategies under development by health insurers to manage biopharmaceuticals, as their use spreads beyond rare diseases and academic sub-specialists to common conditions and community-based practices. Emphasis is placed on medical management (formulary placement and prior authorization), network design (physician contracting and drug distribution), and benefit design (coinsurance and annual payment limits). Contemporary initiatives are modest in ambition but potentially lay the foundation for a framework that balances access to innovation with affordability in this dynamic industry.

                      What's this?